Shopping Cart 0
Cart Subtotal
AED 0

Acorda Therapeutics, Inc. - Strategy, SWOT and Corporate Finance Report

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 642

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 1285

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 1927

Details

Acorda Therapeutics, Inc.-Strategy, SWOT and Corporate Finance Report

Summary

Acorda Therapeutics, Inc.-Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Highlights

Acorda Therapeutics (Acorda or 'the company') is a commercial-stage biotechnology company. It is engaged in the development and marketing of therapies to help restore function in persons with spinal cord injury, multiple sclerosis and related conditions of the central nervous system. The company primarily operates in the US, where it is headquartered in Ardsley, New York.

Scope

- Detailed information on Acorda Therapeutics, Inc. required for business and competitor intelligence needs

- A study of the major internal and external factors affecting Acorda Therapeutics, Inc. in the form of a SWOT analysis

- An in-depth view of the business model of Acorda Therapeutics, Inc. including a breakdown and examination of key business segments

- Intelligence on Acorda Therapeutics, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

- News about Acorda Therapeutics, Inc., such as business expansion, restructuring, and contract wins

- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Acorda Therapeutics, Inc. and the factors that influence its strategies.

- Track strategic initiatives of the company and latest corporate news and actions.

- Assess Acorda Therapeutics, Inc. as a prospective partner, vendor or supplier.

- Support sales activities by understanding your customers' businesses better.

- Stay up to date on Acorda Therapeutics, Inc.'s business structure, strategy and prospects.

READ MORE

Table Of Content

Scope

Table of Contents

Company Snapshot 2

Table of Contents 5

Acorda Therapeutics, Inc.: Company Overview 9

Acorda Therapeutics, Inc.: Overview and Key Facts 9

Acorda Therapeutics, Inc.: Overview 9

Acorda Therapeutics, Inc.: Key Facts 9

Acorda Therapeutics, Inc.: Key Employees 11

Acorda Therapeutics, Inc.: Key Employee Biographies 12

Acorda Therapeutics, Inc.: Major Products and Services 19

Acorda Therapeutics, Inc.: Company History 20

Acorda Therapeutics, Inc.: Management Statement 23

Acorda Therapeutics, Inc.: Locations and Subsidiaries 25

Acorda Therapeutics, Inc.: Key Competitors 26

Acorda Therapeutics, Inc.: Company Analysis 27

Acorda Therapeutics, Inc.: Business Description 27

Acorda Therapeutics, Inc.: SWOT Analysis 28

Acorda Therapeutics, Inc.: SWOT Overview 28

Acorda Therapeutics, Inc.: Strengths 28

Acorda Therapeutics, Inc.: Weaknesses 29

Acorda Therapeutics, Inc.: Opportunities 29

Acorda Therapeutics, Inc.: Threats 30

Acorda Therapeutics, Inc.: Corporate Financial Deals Activity 32

Acorda Therapeutics, Inc.: Financial Deals Overview 32

Acorda Therapeutics, Inc.: Targets and Partners 34

Acorda Therapeutics, Inc.: Top Deals 2014-2018YTD 35

Acorda Therapeutics, Inc.: Advisors 36

Acorda Therapeutics, Inc.: Top Legal Advisors 36

Acorda Therapeutics, Inc.: Top Financial Advisors 36

Acorda Therapeutics, Inc.: Mergers and Acquisitions 37

Acorda Therapeutics, Inc.: Private Equity and Ownership 38

Acorda Therapeutics, Inc.: Recent Developments 39

Acorda Therapeutics, Inc.: News and Events Summary 39

Acorda Therapeutics, Inc.: Corporate Governance 42

Acorda Therapeutics, Inc.: Financial Performance 42

Acorda Therapeutics, Inc.: Market Developments 43

Acorda Therapeutics, Inc.: Red Flags/DistressSignals 44

Acorda Therapeutics, Inc.: Research & Development 44

Acorda Therapeutics, Inc.: Strategy and Operations 45

Appendix 47

Contact Us 47

Methodology 47

About MarketLine 48


List Of Figure

List of Figures

Figure 1: Acorda Therapeutics, Inc.: Deal Activity by Deal Type-Volume (TTM )

Figure 2: Acorda Therapeutics, Inc.: Deal Activity by Deal Type-Volume (2014-YTD 2018)

Figure 3: Acorda Therapeutics, Inc.: M&A Average Deal Size-Value (USD m)

Figure 4: Acorda Therapeutics, Inc.: M&A Volume and Value Trend (2014-YTD 2018)

Figure 5: Acorda Therapeutics, Inc.: M&A Activity by Geography (2014-YTD 2018)

Figure 6: Acorda Therapeutics, Inc.: Private Equity and Ownership Volume and Value Trend (2014-YTD 2018)

Figure 7: Acorda Therapeutics, Inc.: Private Equity and Ownership Volume by Deal Type (2014-YTD 2018)


List Of Table

List of Tables

Table 1: Acorda Therapeutics, Inc.: Key Facts

Table 2: Acorda Therapeutics, Inc.: Key Employees

Table 3: Acorda Therapeutics, Inc.: Locations and Subsidiaries

Table 4: Acorda Therapeutics, Inc.: Key Competitors

Table 5: Acorda Therapeutics, Inc.: Deal Activity by Deal Type-Volume (TTM )

Table 6: Acorda Therapeutics, Inc.: Deal Activity by Deal Type-Volume (2014-YTD 2018)

Table 7: Acorda Therapeutics, Inc.: M&A Average Deal Size-Value (USD m)

Table 8: Acorda Therapeutics, Inc.: Targets and Partners

Table 9: Acorda Therapeutics, Inc.: Top Deals 2014-2018YTD

Table 10: Acorda Therapeutics, Inc.: Legal Advisor Ranking by Value (USD m)

Table 11: Acorda Therapeutics, Inc.: Financial Advisor Ranking by Value (USD m)

Table 12: Acorda Therapeutics, Inc.: M&A Volume and Value Trend (2014-YTD 2018)

Table 13: Acorda Therapeutics, Inc.: M&A Activity by Geography (2014-YTD 2018)

Table 14: Acorda Therapeutics, Inc.: Private Equity and Ownership Volume and Value Trend (2014-YTD 2018)

Table 15: Acorda Therapeutics, Inc.: Private Equity and Ownership Volume by Deal Type (2014-YTD 2018)

Table 16: Acorda Therapeutics, Inc.: News and Events Summary

Table 17: Acorda Therapeutics, Inc.: Corporate Governance

Table 18: Acorda Therapeutics, Inc.: Financial Performance

Table 19: Acorda Therapeutics, Inc.: Market Developments

Table 20: Acorda Therapeutics, Inc.: Red Flags/DistressSignals

Table 21: Acorda Therapeutics, Inc.: Research & Development

Table 22: Acorda Therapeutics, Inc.: Strategy and Operations

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Company Profile

Company Profile Title

Acorda Therapeutics, Inc.-Strategy, SWOT and Corporate Finance Report

Summary

Acorda Therapeutics, Inc.-Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Highlights

Acorda Therapeutics (Acorda or 'the company') is a commercial-stage biotechnology company. It is engaged in the development and marketing of therapies to help restore function in persons with spinal cord injury, multiple sclerosis and related conditions of the central nervous system. The company primarily operates in the US, where it is headquartered in Ardsley, New York.

Scope

- Detailed information on Acorda Therapeutics, Inc. required for business and competitor intelligence needs

- A study of the major internal and external factors affecting Acorda Therapeutics, Inc. in the form of a SWOT analysis

- An in-depth view of the business model of Acorda Therapeutics, Inc. including a breakdown and examination of key business segments

- Intelligence on Acorda Therapeutics, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

- News about Acorda Therapeutics, Inc., such as business expansion, restructuring, and contract wins

- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Acorda Therapeutics, Inc. and the factors that influence its strategies.

- Track strategic initiatives of the company and latest corporate news and actions.

- Assess Acorda Therapeutics, Inc. as a prospective partner, vendor or supplier.

- Support sales activities by understanding your customers' businesses better.

- Stay up to date on Acorda Therapeutics, Inc.'s business structure, strategy and prospects.

READ MORE

Scope

Table of Contents

Company Snapshot 2

Table of Contents 5

Acorda Therapeutics, Inc.: Company Overview 9

Acorda Therapeutics, Inc.: Overview and Key Facts 9

Acorda Therapeutics, Inc.: Overview 9

Acorda Therapeutics, Inc.: Key Facts 9

Acorda Therapeutics, Inc.: Key Employees 11

Acorda Therapeutics, Inc.: Key Employee Biographies 12

Acorda Therapeutics, Inc.: Major Products and Services 19

Acorda Therapeutics, Inc.: Company History 20

Acorda Therapeutics, Inc.: Management Statement 23

Acorda Therapeutics, Inc.: Locations and Subsidiaries 25

Acorda Therapeutics, Inc.: Key Competitors 26

Acorda Therapeutics, Inc.: Company Analysis 27

Acorda Therapeutics, Inc.: Business Description 27

Acorda Therapeutics, Inc.: SWOT Analysis 28

Acorda Therapeutics, Inc.: SWOT Overview 28

Acorda Therapeutics, Inc.: Strengths 28

Acorda Therapeutics, Inc.: Weaknesses 29

Acorda Therapeutics, Inc.: Opportunities 29

Acorda Therapeutics, Inc.: Threats 30

Acorda Therapeutics, Inc.: Corporate Financial Deals Activity 32

Acorda Therapeutics, Inc.: Financial Deals Overview 32

Acorda Therapeutics, Inc.: Targets and Partners 34

Acorda Therapeutics, Inc.: Top Deals 2014-2018YTD 35

Acorda Therapeutics, Inc.: Advisors 36

Acorda Therapeutics, Inc.: Top Legal Advisors 36

Acorda Therapeutics, Inc.: Top Financial Advisors 36

Acorda Therapeutics, Inc.: Mergers and Acquisitions 37

Acorda Therapeutics, Inc.: Private Equity and Ownership 38

Acorda Therapeutics, Inc.: Recent Developments 39

Acorda Therapeutics, Inc.: News and Events Summary 39

Acorda Therapeutics, Inc.: Corporate Governance 42

Acorda Therapeutics, Inc.: Financial Performance 42

Acorda Therapeutics, Inc.: Market Developments 43

Acorda Therapeutics, Inc.: Red Flags/DistressSignals 44

Acorda Therapeutics, Inc.: Research & Development 44

Acorda Therapeutics, Inc.: Strategy and Operations 45

Appendix 47

Contact Us 47

Methodology 47

About MarketLine 48


List Of Figure

List of Figures

Figure 1: Acorda Therapeutics, Inc.: Deal Activity by Deal Type-Volume (TTM )

Figure 2: Acorda Therapeutics, Inc.: Deal Activity by Deal Type-Volume (2014-YTD 2018)

Figure 3: Acorda Therapeutics, Inc.: M&A Average Deal Size-Value (USD m)

Figure 4: Acorda Therapeutics, Inc.: M&A Volume and Value Trend (2014-YTD 2018)

Figure 5: Acorda Therapeutics, Inc.: M&A Activity by Geography (2014-YTD 2018)

Figure 6: Acorda Therapeutics, Inc.: Private Equity and Ownership Volume and Value Trend (2014-YTD 2018)

Figure 7: Acorda Therapeutics, Inc.: Private Equity and Ownership Volume by Deal Type (2014-YTD 2018)


List Of Table

List of Tables

Table 1: Acorda Therapeutics, Inc.: Key Facts

Table 2: Acorda Therapeutics, Inc.: Key Employees

Table 3: Acorda Therapeutics, Inc.: Locations and Subsidiaries

Table 4: Acorda Therapeutics, Inc.: Key Competitors

Table 5: Acorda Therapeutics, Inc.: Deal Activity by Deal Type-Volume (TTM )

Table 6: Acorda Therapeutics, Inc.: Deal Activity by Deal Type-Volume (2014-YTD 2018)

Table 7: Acorda Therapeutics, Inc.: M&A Average Deal Size-Value (USD m)

Table 8: Acorda Therapeutics, Inc.: Targets and Partners

Table 9: Acorda Therapeutics, Inc.: Top Deals 2014-2018YTD

Table 10: Acorda Therapeutics, Inc.: Legal Advisor Ranking by Value (USD m)

Table 11: Acorda Therapeutics, Inc.: Financial Advisor Ranking by Value (USD m)

Table 12: Acorda Therapeutics, Inc.: M&A Volume and Value Trend (2014-YTD 2018)

Table 13: Acorda Therapeutics, Inc.: M&A Activity by Geography (2014-YTD 2018)

Table 14: Acorda Therapeutics, Inc.: Private Equity and Ownership Volume and Value Trend (2014-YTD 2018)

Table 15: Acorda Therapeutics, Inc.: Private Equity and Ownership Volume by Deal Type (2014-YTD 2018)

Table 16: Acorda Therapeutics, Inc.: News and Events Summary

Table 17: Acorda Therapeutics, Inc.: Corporate Governance

Table 18: Acorda Therapeutics, Inc.: Financial Performance

Table 19: Acorda Therapeutics, Inc.: Market Developments

Table 20: Acorda Therapeutics, Inc.: Red Flags/DistressSignals

Table 21: Acorda Therapeutics, Inc.: Research & Development

Table 22: Acorda Therapeutics, Inc.: Strategy and Operations

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS